XML 83 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Collaboration and License Agreements - Revenue (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]      
Revenue $ 240,735 $ 243,231 $ 138,287
GSK      
Disaggregation of Revenue [Line Items]      
Revenue 29,657 124,764 0
Horizon      
Disaggregation of Revenue [Line Items]      
Revenue 23,206 29,181 6,816
Takeda      
Disaggregation of Revenue [Line Items]      
Revenue 162,516 85,834 90,784
Janssen      
Disaggregation of Revenue [Line Items]      
Revenue 356 3,452 40,687
Amgen      
Disaggregation of Revenue [Line Items]      
Revenue $ 25,000 $ 0 $ 0